Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 39Neoplasms 16Neoplasm Metastasis 8Colorectal Neoplasms 5Thyroid Neoplasms 3Skin Neoplasms 2Recurrence 2Leukemia, Hairy Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Thyroid cancer, follicular 1Thyroid Cancer, Papillary 1Skin Diseases 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pancreatic Neoplasms 1Osteosarcoma 1Noonan syndrome 3 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Unknown Primary 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Histiocytosis, Langerhans-Cell 1Heterotaxy Syndrome 1Hepatoblastoma 1Glioma 1

Interventions

Nivolumab 13Surveys and Questionnaires 6Ipilimumab 6linrodostat 5Standard of Care 5Paclitaxel 5Bevacizumab 5Sirolimus 4Pemetrexed 4Interviews as Topic 4Gemcitabine 4Docetaxel 4ARRY-334543 4temsirolimus 3relatlimab 3Erlotinib Hydrochloride 3Cetuximab 3Carboplatin 3regorafenib 2anlotinib 2abemaciclib 2Vorinostat 2Trastuzumab 2Sorafenib 2N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2Magnetic Resonance Spectroscopy 2Doxorubicin 2Dasatinib 2Cyclophosphamide 2vorolanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Cancer × Vemurafenib × Clear all
NCT01596140 2020-06-04

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
27 enrolled
Other solid neoplasm

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡